Skip to main content
Clinical Trials/DRKS00033188
DRKS00033188
Recruiting
Not Applicable

Exploring the modulatory effects of gut microbiota on cholangiocarcinoma progression in a patient-derived organoid model

nimedizin Mainz, Klinik für Allgemein-, Viszeral- und Transplantationschirurgie0 sites20 target enrollmentJanuary 30, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cholangiocarcinoma
Sponsor
nimedizin Mainz, Klinik für Allgemein-, Viszeral- und Transplantationschirurgie
Enrollment
20
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 30, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
nimedizin Mainz, Klinik für Allgemein-, Viszeral- und Transplantationschirurgie

Eligibility Criteria

Inclusion Criteria

  • Histologically confirmed diagnosis of cholangiocarcinoma
  • No known liver\-damaging diseases or other malignat diseases in medical history

Exclusion Criteria

  • Children and adolescents
  • Emergency surgery
  • Diagnosis of primary sclerosing cholangitis or other liver\-damaging disease
  • Liver cirrhosis
  • Lack of compliance
  • Cognitive impairment (e.g. dementia)
  • Histologically confirmed diagnosis of another liver carcinoma
  • Diagnosis of gallbladder carcinoma

Outcomes

Primary Outcomes

Not specified

Similar Trials